• Collegium Pharmaceutical awarded 50,305 restricted stock units on June 1, 2026 under its 2026 Inducement Plan.
• Grants covered 34 newly hired, non-executive employees; each RSU converts into one common share upon vesting.
• Vesting starts June 10, 2027 for one-third, with the remainder vesting in equal annual installments over the next two years.
• RSUs will be settled in common stock on each vesting date, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collegium Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606050800PRIMZONEFULLFEED9731327) on June 05, 2026, and is solely responsible for the information contained therein.